Literature DB >> 23643518

Chagas disease (American trypanosomiasis) in Mexico: an update.

Alejandro Carabarin-Lima1, María Cristina González-Vázquez, Olivia Rodríguez-Morales, Lidia Baylón-Pacheco, José Luis Rosales-Encina, Pedro Antonio Reyes-López, Minerva Arce-Fonseca.   

Abstract

Chagas disease is a parasitic infection caused by the protozoan Trypanosoma cruzi, a flagellated organism that is transmitted mainly to humans through the infected feces of triatomine kissing bugs (vector transmission in endemic areas) or by transfusion of infected blood, donations of infected organ, or transmission from an infected mother to her child at birth. Chagas disease was first described in 1909 by the Brazilian physician Carlos Chagas, and due to the parasite's distribution throughout North, Central and South America, the disease is commonly known as American trypanosomiasis. However, this disease is now present in non-endemic countries such as Canada, the United States of America, and several countries in Europe (principally Spain). Moreover, Chagas disease was recently designated by the World Health Organization as one of the main neglected tropical diseases. The aim of this review is to summarize the research efforts recently described in studies conducted in Mexico on Chagas disease. In this country, there are no existing vector control programs. In addition, there is no consensus on the diagnostic methods for acute and chronic Chagas disease in maternity wards and blood banks, and trypanocidal therapy is not administered to chronic patients. The actual prevalence of the disease is unknown because no official reporting of cases is performed. Therefore, the number of people infected by different routes of transmission (vector, congenital, blood transfusion, organ transplantation, or oral) is unknown. We believe that by promoting education about Chagas disease in schools starting at the basic elementary level and including reinforcement at higher education levels will ensure that the Mexican population would be aware of this health problem and that the control measures adopted will have more acceptance and success. We hope that this review sensitizes the relevant authorities and that the appropriate measures to reduce the risk of infection by T. cruzi are undertaken to provide the Mexican people a better quality of life.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643518     DOI: 10.1016/j.actatropica.2013.04.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  32 in total

1.  A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico.

Authors:  Ellen M Shelly; Rodolfo Acuna-Soto; Kacey C Ernst; Charles R Sterling; Heidi E Brown
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  Circulation of Tc Ia discrete type unit Trypanosoma cruzi in Yucatan Mexico.

Authors:  Victor Monteón; Omar Triana-Chávez; Ana Mejía-Jaramillo; Pamela Pennignton; Ángel Ramos-Ligonio; Karla Acosta; Ruth Lopez
Journal:  J Parasit Dis       Date:  2014-07-27

3.  Oral infection of mice and host cell invasion by Trypanosoma cruzi strains from Mexico.

Authors:  Cecilia G Barbosa; César Gómez-Hernández; Karine Rezende-Oliveira; Marcos Vinicius Da Silva; João Paulo Ferreira Rodrigues; Monique G S Tiburcio; Thatiane Bragini Ferreira; Virmondes Rodrigues; Nobuko Yoshida; Luis E Ramirez
Journal:  Parasitol Res       Date:  2019-03-08       Impact factor: 2.289

4.  Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study.

Authors:  L Zumaquero-Ríos; J Sarracent-Pérez; C Sandoval-Ruiz; R M Aldana-Arnas; A López-Monteon; J Torres-Montero; D Guzmán-Gómez; A Ramos-Ligonio
Journal:  Acta Parasitol       Date:  2019-09-30       Impact factor: 1.440

5.  Congenital Transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: An Observational Prospective Study.

Authors:  Pierre Buekens; María Luisa Cafferata; Jackeline Alger; Fernando Althabe; José M Belizán; Norma Bustamante; Yves Carlier; Alvaro Ciganda; Jaime H Del Cid; Eric Dumonteil; Rubí Gamboa-León; Jorge A García; Luz Gibbons; Olga Graiff; Jesús Gurubel Maldonado; Claudia Herrera; Elizabeth Howard; Laura Susana Lara; Benjamín López; María Luisa Matute; María Jesús Ramírez-Sierra; María Cecilia Robles; Sergio Sosa-Estani; Carine Truyens; Christian Valladares; Dawn M Wesson; Concepción Zúniga
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

6.  Chagas Disease: A Solvable Problem, Ignored.

Authors:  Rick L Tarleton
Journal:  Trends Mol Med       Date:  2016-08-11       Impact factor: 11.951

7.  A survey of zoonotic pathogens carried by house mouse and black rat populations in Yucatan, Mexico.

Authors:  J A Panti-May; R R C DE Andrade; Y Gurubel-González; E Palomo-Arjona; L Sodá-Tamayo; J Meza-Sulú; M Ramírez-Sierra; E Dumonteil; V M Vidal-Martínez; C Machaín-Williams; D DE Oliveira; M G Reis; M A Torres-Castro; M R Robles; S F Hernández-Betancourt; F Costa
Journal:  Epidemiol Infect       Date:  2017-07-10       Impact factor: 4.434

8.  Social Representations and Practices Towards Triatomines and Chagas Disease in Calakmul, México.

Authors:  Alba Valdez-Tah; Laura Huicochea-Gómez; Judith Ortega-Canto; Austreberta Nazar-Beutelspacher; Janine M Ramsey
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

9.  Chagas Disease Infection among Migrants at the Mexico/Guatemala Border.

Authors:  Erin E Conners; Teresa López Ordoñez; Celia Cordon-Rosales; Carmen Fernández Casanueva; Sonia Morales Miranda; Kimberly C Brouwer
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

Review 10.  Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?

Authors:  Alejandro Diaz-Hernandez; Maria Cristina Gonzalez-Vazquez; Minerva Arce-Fonseca; Olivia Rodriguez-Morales; Maria Lilia Cedilllo-Ramirez; Alejandro Carabarin-Lima
Journal:  Biology (Basel)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.